トリプトレリンの世界市場：規模、シェア、動向、予測（2022年～2028年）

世界のトリプトレリンの市場規模は、前立腺がんや唾液腺がんの発生率の増加、および8～9歳以下の若年層における中枢性思春期早発症の有病率の上昇、術後補助療法としての使用可能性などによって促進されています。

当レポートでは、世界のトリプトレリン市場を調査しており、市場の概要、市場規模や予測、動向、成長要因、抑制要因、薬剤タイプ・用途・地域別の分析、および競合情勢などを提供しています。

目次

第1章 調査目的・前提条件

• 調査目的
• 仮定
• 略語

第2章 市場概要

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
  • 市場内訳：薬剤タイプ別
  • 市場内訳：用途別
  • 市場内訳：流通チャネル別
  • 市場内訳：地域別
• コヒーレントオポチュニティマップ（COM）

第3章 市場力学、規制、および動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 規制シナリオ
• 市場動向
• 疫学
• 新製品の承認/発売
• 合併/買収
• 戦略的コラボレーション
• PEST分析

第4章 世界のトリプトレリン市場：薬剤タイプ別（2017年～2028年）

• イントロダクション
• トリプトレリンパモエート
• 酢酸トリプトレリン
• トリプトレリンエンボネート

第5章 世界のトリプトレリン市場：用途別（2017年～2028年）

• イントロダクション
• 前立腺がん
• 前立腺全摘除術
• 子宮内膜症
• 唾液腺がん
• 中枢性思春期早発症

第6章 世界のトリプトレリン市場：流通チャネル別（2017年～2028年）

• イントロダクション
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 世界のトリプトレリン市場：地域別（2017年～2028年）

• イントロダクション
• 北米
• 米国
• カナダ
• 欧州
• 英国
• ドイツ
• イタリア
• フランス
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• 中国
• 日本
• インド
• ASEAN
• オーストラリア
• 韓国
• その他アジア太平洋
• ラテンアメリカ
• ブラジル
• メキシコ
• アルゼンチン
• その他ラテンアメリカ
• アフリカ
• 北アフリカ
• 中央アフリカ
• 南アフリカ
• 中東
• GCC諸国
• イスラエル
• その他中東

第8章 競合情勢

• ヒートマップ分析
• 企業プロファイル
  • Ipsen
  • Bachem
  • Ferring Pharmaceuticals Pvt Ltd.
  • Chengdu Tiantaishan pharmaceutical Co., Ltd.
  • Tecnofarma
  • Dr. Reddy's Laboratories Ltd.
  • Teva Pharmaceutical Industries Ltd.(Actavis Specialty Pharmaceuticals Co.)
  • Debiopharm Group
  • Arbor Pharmaceuticals, LLC
• アナリストの見解

第9章 セクション

Triptorelin is a peptide formulation for injection that was developed mainly for the treatment of advanced metastatic prostate cancer. Furthermore, other indications developed subsequently include the treatment of uterine fibroids (a benign tumor of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilization). Other modalities of triptorelin such as triptorelin acetate, triptorelin pamoate and triptorelin embonate are also used for prostate cancer treatment.

Market Dynamics

Triptorelin market is expected to witness lucrative growth opportunities during forecast period, owing to increasing incidence of prostate cancer and salivary gland cancer and increasing prevalence of central precocious puberty among the young patients below age eight and nine years, worldwide. For instance, according to National Organization for Rare Disorders (NORD), 2016 data findings, Central Precocious Puberty (CPP), accounted for 1 to 5 in 10,000 children with a female to male ratio of about 20:1, in U.S.

In March 2021, Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, in coordination with fourteen other European regulatory agencies approved a new indication of Decapeptyl (triptorelin). According to these new indication, Decapeptyl (triptorelin) will be used as adjuvant treatment in combination with tamoxifen or aromatase inhibitor for endocrine-responsive early-stage breast cancer in women at high-risk of recurrence who are confirmed as pre-menopausal after completion of chemotherapy. This would enhance the revenue for growth for triptorelin market, during forecast period.

Furthermore, higher efficacy and tolerability of triptorelin in suppression of gonadotropin secretion in prostate cancer and precocious puberty is increasing adoption of triptorelin in the market.

Key features of the study:

This report provides in-depth analysis of triptorelin market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global triptorelin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study include Ipsen, Bachem, Ferring Pharmaceuticals Pvt Ltd., Chengdu Tiantaishan pharmaceutical Co., Ltd., Tecnofarma, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.), Debiopharm Group, and Arbor Pharmaceuticals, LLC.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global triptorelin market report caters to various stakeholders in this industry including investors, suppliers, triptorelin based product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the triptorelin market.

Detailed Segmentation:

Global Triptorelin Market, By Drug Type:

Triptorelin Pamoate

Triptorelin Acetate

Triptorelin Embonate

Global Triptorelin Market, By Application:

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

Global Triptorelin Market, By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Global Triptorelin Market, By Geography:

North America

By Country:

U.S.

Canada

By Drug Type:

Decapeptyl SR

Trelstar

Decapeptyl SR

Gonapeptyl depot

Salvacyl

Triptorelin pamoate

Triptorelin acetate

Triptorelin embonate

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Europe

By Country:

Germany

France

Italy

UK

Spain

Russia

Rest of Europe

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Asia Pacific

By Country:

China

India

Japan

South Korea

Australia

Rest of Asia Pacific

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Middle East

By Country:

GCC

Israel

Rest of Middle East

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Latin America

By Country:

Brazil

Argentina

Mexico

Rest of Latin America

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Africa

By Country:

South Africa

Central Africa

North Africa

By Drug Type:

Triptorelin pamoate

Decapeptyl SR

Trelstar

Triptorelin acetate

Decapeptyl SR

Gonapeptyl depot

Triptorelin embonate

Salvacyl

By Application

Prostate Cancer

Radical Prostatectomy

Endometriosis

Salivary Gland Cancer

Central Precocious Puberty

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Company Profiles

Ipsen *

Company Overview

Product Portfolio

Financial Performance

Recent Developments

Strategies

Bachem

Ferring Pharmaceuticals Pvt Ltd.

Chengdu Tiantaishan pharmaceutical Co., Ltd.

Tecnofarma

Reddy’s Laboratories Ltd.

Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)

Debiopharm Group

Arbor Pharmaceuticals, LLC

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Application
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Regulatory Scenario
• Market Trends
• Epidemiology
• New Product Approvals/Launch
• Mergers/ Acquisition
• Strategic Collaborations
• PEST Analysis

4. Global Triptorelin Market, By Drug Type, 2017-2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Triptorelin pamoate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Triptorelin acetate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Triptorelin embonate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Triptorelin Market, By Application, 2017-2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Prostate Cancer
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
• Radical Prostatectomy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Endometriosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Salivary Gland Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Central Precocious Puberty
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Triptorelin Market, By Distribution Channel, 2017-2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospital Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Retail Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Online Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Triptorelin Market, By Regions, 2017-2028 (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• U.S.
• Canada
• Europe
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Africa
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• North Africa
• Central Africa
• South Africa
• Middle East
  • Market Size and Forecast, By Drug Type, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Application, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2017-2028 (US$ Million)
  • Market Size and Forecast, By Country, 2017-2028, (US$ Million)
• GCC Countries
• Israel
• Rest of Middle East

8. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Ipsen
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Bachem
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Ferring Pharmaceuticals Pvt Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Chengdu Tiantaishan pharmaceutical Co., Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Tecnofarma
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Dr. Reddy's Laboratories Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Debiopharm Group
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Arbor Pharmaceuticals, LLC
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Analyst Views

9. Section

• References
• Analyst Views
• Research Methodology
• About Us and Sales Contact